266 related articles for article (PubMed ID: 20040570)
1. A histone chaperone, DEK, transcriptionally coactivates a nuclear receptor.
Sawatsubashi S; Murata T; Lim J; Fujiki R; Ito S; Suzuki E; Tanabe M; Zhao Y; Kimura S; Fujiyama S; Ueda T; Umetsu D; Ito T; Takeyama K; Kato S
Genes Dev; 2010 Jan; 24(2):159-70. PubMed ID: 20040570
[TBL] [Abstract][Full Text] [Related]
2. The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity.
Kappes F; Waldmann T; Mathew V; Yu J; Zhang L; Khodadoust MS; Chinnaiyan AM; Luger K; Erhardt S; Schneider R; Markovitz DM
Genes Dev; 2011 Apr; 25(7):673-8. PubMed ID: 21460035
[TBL] [Abstract][Full Text] [Related]
3. The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.
Sandén C; Järvstråt L; Lennartsson A; Brattås PL; Nilsson B; Gullberg U
Mol Cancer; 2014 Sep; 13():215. PubMed ID: 25216995
[TBL] [Abstract][Full Text] [Related]
4. Bacterial Growth Inhibition Screen (BGIS) identifies a loss-of-function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin.
Guo H; Prell M; Königs H; Xu N; Waldmann T; Hermans-Sachweh B; Ferrando-May E; Lüscher B; Kappes F
FEBS Lett; 2021 May; 595(10):1438-1453. PubMed ID: 33686684
[TBL] [Abstract][Full Text] [Related]
5. The PML-associated protein DEK regulates the balance of H3.3 loading on chromatin and is important for telomere integrity.
Ivanauskiene K; Delbarre E; McGhie JD; Küntziger T; Wong LH; Collas P
Genome Res; 2014 Oct; 24(10):1584-94. PubMed ID: 25049225
[TBL] [Abstract][Full Text] [Related]
6. Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias.
Karam M; Thenoz M; Capraro V; Robin JP; Pinatel C; Lancon A; Galia P; Sibon D; Thomas X; Ducastelle-Lepretre S; Nicolini F; El-Hamri M; Chelghoun Y; Wattel E; Mortreux F
Neoplasia; 2014 Jan; 16(1):21-30. PubMed ID: 24563617
[TBL] [Abstract][Full Text] [Related]
7. SET and PARP1 remove DEK from chromatin to permit access by the transcription machinery.
Gamble MJ; Fisher RP
Nat Struct Mol Biol; 2007 Jun; 14(6):548-55. PubMed ID: 17529993
[TBL] [Abstract][Full Text] [Related]
8. The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes.
McGarvey T; Rosonina E; McCracken S; Li Q; Arnaout R; Mientjes E; Nickerson JA; Awrey D; Greenblatt J; Grosveld G; Blencowe BJ
J Cell Biol; 2000 Jul; 150(2):309-20. PubMed ID: 10908574
[TBL] [Abstract][Full Text] [Related]
9. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.
Kappes F; Fahrer J; Khodadoust MS; Tabbert A; Strasser C; Mor-Vaknin N; Moreno-Villanueva M; Bürkle A; Markovitz DM; Ferrando-May E
Mol Cell Biol; 2008 May; 28(10):3245-57. PubMed ID: 18332104
[TBL] [Abstract][Full Text] [Related]
10. Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK.
Ko SI; Lee IS; Kim JY; Kim SM; Kim DW; Lee KS; Woo KM; Baek JH; Choo JK; Seo SB
FEBS Lett; 2006 May; 580(13):3217-22. PubMed ID: 16696975
[TBL] [Abstract][Full Text] [Related]
11. Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.
Capitano ML; Mor-Vaknin N; Saha AK; Cooper S; Legendre M; Guo H; Contreras-Galindo R; Kappes F; Sartor MA; Lee CT; Huang X; Markovitz DM; Broxmeyer HE
J Clin Invest; 2019 May; 129(6):2555-2570. PubMed ID: 31107242
[TBL] [Abstract][Full Text] [Related]
12. Imaging-based study demonstrates how the DEK nanoscale distribution differentially correlates with epigenetic marks in a breast cancer model.
Pierzynska-Mach A; Cainero I; Oneto M; Ferrando-May E; Lanzanò L; Diaspro A
Sci Rep; 2023 Aug; 13(1):12749. PubMed ID: 37550322
[TBL] [Abstract][Full Text] [Related]
13. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
[TBL] [Abstract][Full Text] [Related]
14. C/EBPα and DEK coordinately regulate myeloid differentiation.
Koleva RI; Ficarro SB; Radomska HS; Carrasco-Alfonso MJ; Alberta JA; Webber JT; Luckey CJ; Marcucci G; Tenen DG; Marto JA
Blood; 2012 May; 119(21):4878-88. PubMed ID: 22474248
[TBL] [Abstract][Full Text] [Related]
15. The Complexity of DEK Signaling in Cancer Progression.
Teng Y; Lang L; Jauregui CE
Curr Cancer Drug Targets; 2018; 18(3):256-265. PubMed ID: 28530531
[TBL] [Abstract][Full Text] [Related]
16. DEK over-expression promotes mitotic defects and micronucleus formation.
Matrka MC; Hennigan RF; Kappes F; DeLay ML; Lambert PF; Aronow BJ; Wells SI
Cell Cycle; 2015; 14(24):3939-53. PubMed ID: 25945971
[TBL] [Abstract][Full Text] [Related]
17. Drosophila histone H2A variant (H2Av) controls poly(ADP-ribose) polymerase 1 (PARP1) activation in chromatin.
Kotova E; Lodhi N; Jarnik M; Pinnola AD; Ji Y; Tulin AV
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6205-10. PubMed ID: 21444826
[TBL] [Abstract][Full Text] [Related]
18. Caspase-dependent apoptosis induction by targeted expression of DEK in Drosophila involves histone acetylation inhibition.
Lee KS; Kim DW; Kim JY; Choo JK; Yu K; Seo SB
J Cell Biochem; 2008 Mar; 103(4):1283-93. PubMed ID: 17685435
[TBL] [Abstract][Full Text] [Related]
19. Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR.
Sandén C; Ageberg M; Petersson J; Lennartsson A; Gullberg U
BMC Cancer; 2013 Sep; 13():440. PubMed ID: 24073922
[TBL] [Abstract][Full Text] [Related]
20.
Panagopoulos I; Gorunova L; Torkildsen S; Tjønnfjord GE; Micci F; Heim S
Cancer Genomics Proteomics; 2017; 14(6):437-443. PubMed ID: 29109093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
